Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1+ subpopulation

Regenerative Medicine

Volumn 9, Issue 6, 2014, Pages 723-732

  Devito, Liani ^a   Badraiq, Heba ^a   Galleu, Antonio ^a   Taheem, Dheraj K ^a   Codognotto, Stefano ^a   Siow, Richard ^a   Khalaf, Yacoub ^a   Briley, Annette ^a   Shennan, Andrew ^a   Poston, Lucilla ^a   McGrath, John ^a   Gentleman, Eileen ^a   Dazzi, Francesco ^a   Ilic, Dusko ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

animal product free culture; chemically defined condition; mesenchymal stem cell; mesenchymal stromal cell; MSCA 1; umbilical cord; Wharton's jelly

Indexed keywords

CELL ANTIGEN; MSC ANTIGEN 1; UNCLASSIFIED DRUG; OXYGEN;

ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL STRUCTURE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MULTIPOTENT STEM CELL; OXYGEN CONCENTRATION; SCALE UP; STEM CELL CULTURE; STEM CELL EXPANSION; WHARTON JELLY; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; FLOW CYTOMETRY; METABOLISM; PROCEDURES; SERUM; UMBILICAL CORD;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STROMAL CELLS; OXYGEN; SERUM; UMBILICAL CORD; WHARTON JELLY;

EID: 84913612290     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.14.60     Document Type: Article

References (40)

1. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3 (4), 393-403 (1974).
2. Horwitz EM, Le Blanc K, Dominici M et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7 (5), 393-395 (2005).
3. Jones EA, English A, Kinsey SE et al. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin. Cytom. 70 (6), 391-399 (2006).
4. Sobiesiak M, Sivasubramaniyan K, Hermann C et al. The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev. 19 (5), 669-677 (2010).
5. Bühring HJ, Treml S, Cerabona F, de Zwart P, Kanz L, Sobiesiak M. Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann. NY Acad. Sci. 1176, 124-134 (2009).
6. Battula VL, Treml S, Bareiss PM et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 94 (2), 173-184 (2009).
7. Gronthos S, Fitter S, Diamond P, Simmons PJ, Itescu S, Zannettino AC. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells Dev. 16 (6), 953-963 (2007).
8. Pikuła M, Marek-Trzonkowska N, Wardowska A, Renkielska A, Trzonkowski P. Adipose tissue-derived stem cells in clinical applications. Expert Opin. Biol. Ther. 13 (10), 1357-1370 (2013).
9. Tran TT, Kahn CR. Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat. Rev. Endocrinol. 6 (4), 195-213 (2010).
10. La Rocca G, Lo Iacono M, Corsello T, Corrao S, Farina F, Anzalone R. Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy. Curr. Stem Cell Res. Ther. 8 (1), 100-113 (2013).
11. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26 (3), 591-599 (2008).
12. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 14 (9), 12 (2011).
13. Lo Iacono M, Anzalone R, Corrao S, Zummo G, Farina F, La Rocca G. Nonclassical type I HLAs and B7 costimulators revisited: analysis of expression and immunomodulatory role in undifferentiated and differentiated MSC isolated from human umbilical cord Wharton's jelly. Histol. Histopathol. 26 (Suppl. 1), 313 (2011).
14. Weiss ML, Anderson C, Medicetty S et al. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26 (11), 2865-2874 (2008).
15. Sobolewski K, Bańkowski E, Chyczewski L, Jaworski S. Collagen and glycosaminoglycans of Wharton's jelly. Biol. Neonate 71 (1), 11-21 (1997).
16. Corrao S, La Rocca G, Lo Iacono M, Corsello T, Farina F, Anzalone R. Umbilical cord revisited: from Wharton's jelly myofibroblasts to mesenchymal stem cells. Histol Histopathol. 28 (10), 1235-1244 (2013).
17. De Kock J, Najar M, Bolleyn J et al. Mesoderm-derived stem cells: the link between the transcriptome and their differentiation potential. Stem Cells Dev. 21 (18), 3309-3323 (2012).
18. Huang YC, Parolini O, La Rocca G, Deng L. Umbilical cord versus bone marrow-derived mesenchymal stromal cells. Stem Cells Dev. 21 (15), 2900-2903 (2012).
19. Reinisch A, Strunk D. Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs). J. Vis. Exp. 32, 1525 (2009).
20. Marigo I, Dazzi F. The immunomodulatory properties of mesenchymal stem cells. Semin. Immunopathol. 33 (6), 593-602 (2011).
21. Margossian T, Reppel L, Makdissy N, Stoltz JF, Bensoussan D, Huselstein C. Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion. Biomed. Mater. Eng. 22 (4), 243-54 (2012).
22. Hu WH, Mo XM, Walters WM, Brambilla R, Bethea JR. TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation. J. Biol. Chem. 279 (34), 35975-35983 (2004).
23. Pike AF, Kramer NI, Blaauboer BJ, Seinen W, Brands R. A novel hypothesis for an alkaline phosphatase 'rescue' mechanism in the hepatic acute phase immune response. Biochim. Biophys. Acta. 1832 (12), 2044-2056 (2013).
24. Hessle L, Johnson KA, Anderson HC et al. Tissuenonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl Acad. Sci. USA 99 (14), 9445-9449 (2002).
25. Wennberg C, Hessle L, Lundberg P et al. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J. Bone Miner. Res. 15 (10), 1879-1888 (2000).
26. Hanics J, Barna J, Xiao J, Millán JL, Fonta C, Négyessy L. Ablation of TNAP function compromises myelination and synaptogenesis in the mouse brain. Cell Tissue Res. 349 (2), 459-471 (2012).
27. Capelli C, Gotti E, Morigi M et al. Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy 13 (7), 786-801 (2011).
28. Fonta C, Negyessy L, Renaud L, Barone P. Postnatal development of alkaline phosphatase activity correlates with the maturation of neurotransmission in the cerebral cortex. J. Comp. Neurol. 486 (2), 179-196 (2005).
29. Tisato V, Naresh K, Girdlestone J, Navarrete C, Dazzi F. Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia 21 (9), 1992-1999 (2007).
30. Noda Y, Goto Y, Umaoka Y, Shiotani M, Nakayama T, Mori T. Culture of human embryos in alpha modification of Eagle's medium under low oxygen tension and low illumination. Fertil. Steril. 62 (5), 1022-1027 (1994).
31. Waldenström U, Engström AB, Hellberg D, Nilsson S. Low-oxygen compared with high-oxygen atmosphere in blastocyst culture, a prospective randomized study. Fertil. Steril. 91 (6), 2461-2465 (2009).
32. Sun R, Celli A, Crumrine D et al. Lowered humidity produces human epidermalequivalents with enhanced barrier properties. Tissue Eng. Part C Methods doi:10.1089/ ten.tec.2014.0065 (2014) (Epub ahead of print).
33. Petrova A, Celli A, Jacquet L et al. 3D In vitro model of a functional epidermalpermeability barrier from human embryonic stem cells and induced pluripotent stem cells.. Stem Cell Reports 2 (5), 675-689 (2014).
34. Yang S, Pilgaard L, Chase LG et al. Defined xenogeneic-free and hypoxic environment provides superior conditions for long-term expansion of human adipose-derived stem cells. Tissue Eng. Part C Methods 18 (8), 593-602 (2012).
35. López L, Seshareddy K, Trevino E, Cox J, Weiss ML. Evaluating the impact of oxygen concentration and plating density on human Wharton's jelly-derived mesenchymal stromal cells. Open Tissue Eng. Regen. Med. J. 4, 82-94 (2011).
36. Nekanti U, Dastidar S, Venugopal P, Totey S, Ta M. Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia. Int. J. Biol. Sci. 6 (5), 499-512 (2010).
37. Drela K, Sarnowska A, Siedlecka P et al. Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner. Cytotherapy 16 (7), 881-892 (2014).
38. Lavrentieva A, Majore I, Kasper C, Hass R. Effects of hypoxic culture conditions on umbilical cordderived human mesenchymal stem cells. Cell Commun. Signal. 16 (8), 18 (2010).
39. Julavijitphong S, Wichitwiengrat S, Tirawanchai N, Ruangvutilert P, Vantanasiri C, Phermthai T. A xeno-free culture method that enhances Wharton's jelly mesenchymal stromal cell culture efficiency over traditional animal serum-supplemented cultures. Cytotherapy 16 (5), 683-691 (2014).
40. Nekanti U, Mohanty L, Venugopal P, Balasubramanian S, Totey S, Ta M. Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res. 5 (3), 244-254 (2010).